Neurocrine Biosciences Statistics
Total Valuation
NBIX has a market cap or net worth of $13.53 billion. The enterprise value is $12.93 billion.
| Market Cap | 13.53B |
| Enterprise Value | 12.93B |
Important Dates
The next confirmed earnings date is Wednesday, May 1, 2024, before market open.
| Earnings Date | May 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
NBIX has 99.51 million shares outstanding. The number of shares has increased by 2.12% in one year.
| Shares Outstanding | 99.51M |
| Shares Change (YoY) | +2.12% |
| Shares Change (QoQ) | +1.09% |
| Owned by Insiders (%) | 1.00% |
| Owned by Institutions (%) | 94.53% |
| Float | 98.29M |
Valuation Ratios
The trailing PE ratio is 55.06 and the forward PE ratio is 27.82. NBIX's PEG ratio is 0.44.
| PE Ratio | 55.06 |
| Forward PE | 27.82 |
| PS Ratio | 7.17 |
| Forward PS | 5.99 |
| PB Ratio | 6.06 |
| P/FCF Ratio | 37.42 |
| PEG Ratio | 0.44 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 36.11, with an EV/FCF ratio of 35.75.
| EV / Earnings | 51.78 |
| EV / Sales | 6.85 |
| EV / EBITDA | 36.11 |
| EV / EBIT | 38.40 |
| EV / FCF | 35.75 |
Financial Position
The company has a current ratio of 2.45, with a Debt / Equity ratio of 0.19.
| Current Ratio | 2.45 |
| Quick Ratio | 2.25 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | 1.20 |
| Debt / FCF | 1.18 |
| Interest Coverage | 73.20 |
Financial Efficiency
Return on equity (ROE) is 12.90% and return on invested capital (ROIC) is 7.09%.
| Return on Equity (ROE) | 12.90% |
| Return on Assets (ROA) | 9.00% |
| Return on Capital (ROIC) | 7.09% |
| Revenue Per Employee | $1.35M |
| Profits Per Employee | $178,357 |
| Employee Count | 1,400 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 1.08 |
Taxes
In the past 12 months, NBIX has paid $82.40 million in taxes.
| Income Tax | 82.40M |
| Effective Tax Rate | 24.81% |
Stock Price Statistics
The stock price has increased by +32.39% in the last 52 weeks. The beta is 0.28, so NBIX's price volatility has been lower than the market average.
| Beta (1Y) | 0.28 |
| 52-Week Price Change | +32.39% |
| 50-Day Moving Average | 136.55 |
| 200-Day Moving Average | 121.39 |
| Relative Strength Index (RSI) | 48.69 |
| Average Volume (30 Days) | 885,879 |
Short Selling Information
The latest short interest is 2.02 million, so 2.03% of the outstanding shares have been sold short.
| Short Interest | 2.02M |
| Short Previous Month | 2.43M |
| Short % of Shares Out | 2.03% |
| Short % of Float | 2.06% |
| Short Ratio (days to cover) | 2.38 |
Income Statement
In the last 12 months, NBIX had revenue of $1.89 billion and earned $249.70 million in profits. Earnings per share was $2.47.
| Revenue | 1.89B |
| Gross Profit | 1.85B |
| Operating Income | 250.90M |
| Pretax Income | 332.10M |
| Net Income | 249.70M |
| EBITDA | 358.00M |
| EBIT | 336.70M |
| Earnings Per Share (EPS) | $2.47 |
Balance Sheet
The company has $1.03 billion in cash and $428.40 million in debt, giving a net cash position of $603.20 million or $6.06 per share.
| Cash & Cash Equivalents | 1.03B |
| Total Debt | 428.40M |
| Net Cash | 603.20M |
| Net Cash Per Share | $6.06 |
| Equity / Book Value | 2.23B |
| Book Value Per Share | 22.43 |
| Working Capital | 952.20M |
Cash Flow
In the last 12 months, operating cash flow was $389.90 million and capital expenditures -$28.30 million, giving a free cash flow of $361.60 million.
| Operating Cash Flow | 389.90M |
| Capital Expenditures | -28.30M |
| Free Cash Flow | 361.60M |
| FCF Per Share | $3.70 |
Margins
Gross margin is 97.90%, with operating and profit margins of 13.30% and 13.23%.
| Gross Margin | 97.90% |
| Operating Margin | 13.30% |
| Pretax Margin | 17.60% |
| Profit Margin | 13.23% |
| EBITDA Margin | 18.97% |
| EBIT Margin | 17.84% |
| FCF Margin | 19.16% |
Dividends & Yields
NBIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.12% |
| Shareholder Yield | -2.12% |
| Earnings Yield | 1.85% |
| FCF Yield | 2.67% |
Analyst Forecast
The average price target for NBIX is $142.71, which is 4.94% higher than the current price. The consensus rating is "Buy".
| Price Target | $142.71 |
| Price Target Difference | 4.94% |
| Analyst Consensus | Buy |
| Analyst Count | 22 |
| Revenue Growth Forecast (5Y) | 14.35% |
| EPS Growth Forecast (5Y) | 42.06% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NBIX has an Altman Z-Score of 9.17 and a Piotroski F-Score of 4.
| Altman Z-Score | 9.17 |
| Piotroski F-Score | 4 |